16 companies

Showing 1–16 of 16 companies

Nucleome Therapeutics

Nucleome Therapeutics is an Oxford-based biotech company using 3D genome sequencing and machine learning to decode the dark genome and develop precision medicines for immune-mediated inflammatory diseases.

Replimune

Replimune is a clinical-stage biotech developing HSV-1-based oncolytic immunotherapies through its RPx platform, with multiple oncology trials and a 63,000 sq ft U.S. manufacturing facility.

1 open job

MoonLake Immunotherapeutics

Clinical-stage biopharmaceutical company developing Nanobody-based immunotherapies for inflammatory diseases, including hidradenitis suppurativa and inflammatory skin and joint conditions.

arGenX SE

arGenX SE is a global immunology company developing antibody-based treatments, such as VYVGART, for severe autoimmune diseases.

1 open job

GlycoEra AG

GlycoEra AG develops biologics that selectively degrade disease-driving circulating proteins such as autoantibodies, led by GE8820 for pathogenic IgG4 in autoimmune disease.

1 open job

IMU Biosciences

IMU Biosciences, a London biotech, uses AI-driven, multi-omic immune profiling to measure over 100 million immune data points from 2ml of blood and has built a dataset of more than 25,000 samples.

Vaxcyte

Vaxcyte is a clinical-stage vaccine company engineering high-fidelity vaccines against bacterial diseases, led by the 31-valent pneumococcal conjugate vaccine VAX-31.

1 open job

OM Pharma

Swiss biopharmaceutical company developing bacterial lysates and microbial-derived immunotherapeutics to strengthen immune defences and prevent infections.

Alvotech

Alvotech develops, manufactures and commercialises biosimilar medicines through a vertically integrated pipeline targeting immunology, oncology and ophthalmology.

Immunai

Immunai is a biotech company using AI and single-cell multiomics to decode the human immune system and accelerate drug discovery for pharmaceutical partners.

CellCarta

CellCarta is a contract research organization providing specialized laboratory testing in immunology, histopathology, proteomics, and genomics for biopharmaceutical companies.

1 open job

ATB Therapeutics

Belgian biopharmaceutical company developing bifunctional antibody (atbody) therapeutics for cancer and autoimmune disease via its atbiofarm single-step manufacturing platform.

Parallel Bio

Parallel Bio combines a scalable human immune organoid with AI to generate population-scale human biological data for drug discovery, reporting 87% concordance with clinical data.

2 open jobs

Isomorphic Labs

Isomorphic Labs is a British AI drug discovery company, spun out of Google DeepMind in 2021, using AI to model biology, design molecules and develop medicines in oncology and immunology.

1 open job

Autolus

Autolus develops programmed CAR T cell therapies for cancer and autoimmune disease; its AUCATZYL (obe-cel) therapy received FDA approval in November 2024.

1 open job

VIB

VIB is a non-profit life sciences research institute in Flanders, Belgium, conducting research in areas from cancer to plant biology and translating discoveries into spin-offs, diagnostics and therapeutics.

1 open job

16 companies

Nucleome Therapeutics

Replimune

MoonLake Immunotherapeutics

arGenX SE

GlycoEra AG

IMU Biosciences

Vaxcyte

OM Pharma

Alvotech

Immunai

CellCarta

ATB Therapeutics

Parallel Bio

Isomorphic Labs

Autolus

VIB

Browse by market